Boston Scientific Corp (BSX)
Profitability ratios
Return on sales
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 67.02% | 67.30% | 67.15% | 69.14% | 69.32% | 69.14% | 69.22% | 68.75% | 68.44% | 68.48% | 68.49% | 68.59% | 68.38% | 66.95% | 66.43% | 64.43% | 64.57% | 66.71% | 67.74% | 69.84% |
| Operating profit margin | 17.01% | 17.33% | 17.84% | 16.89% | 16.45% | 17.05% | 15.00% | 14.71% | 14.45% | 11.36% | 11.81% | 10.65% | 10.09% | 8.82% | 3.74% | 0.85% | -1.39% | 0.79% | 6.58% | 10.41% |
| Pretax margin | 13.63% | 13.84% | 14.07% | 14.61% | 13.94% | 13.64% | 11.28% | 10.96% | 9.00% | 6.89% | 8.95% | 7.47% | 9.06% | 10.51% | 4.42% | 1.63% | -1.39% | -3.88% | -0.73% | 2.34% |
| Net profit margin | 11.05% | 11.24% | 11.98% | 12.04% | 11.19% | 8.93% | 6.70% | 6.70% | 5.17% | 4.76% | 6.72% | 6.21% | 8.29% | 9.21% | 4.43% | 1.75% | -1.40% | 36.65% | 39.24% | 39.75% |
Boston Scientific Corp has shown a consistent improvement in its profitability ratios over the reporting periods. The gross profit margin has remained relatively stable, ranging from 64.57% to 69.32%, indicating the company's ability to efficiently manage its cost of goods sold.
The operating profit margin has shown significant variability, improving from -1.39% to 17.33% over the same period. This demonstrates the company's efforts in controlling its operating expenses and increasing operational efficiency.
The pretax margin has also displayed a notable positive trend, increasing from -3.88% to 14.61%, indicating the company's improvement in generating profits before taxes.
The net profit margin has seen a remarkable recovery, bouncing back from a negative margin to 11.19% by the end of the reporting period. This highlights the effectiveness of the company in managing its overall profitability after facing challenges in the past.
Overall, Boston Scientific Corp's profitability ratios reflect a positive trend and showcase the company's resilience in improving its profitability over time.
Return on investment
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 7.23% | 7.24% | 7.32% | 6.77% | 6.67% | 6.89% | 5.98% | 5.83% | 5.65% | 4.47% | 4.52% | 4.00% | 3.72% | 3.17% | 1.34% | 0.28% | -0.45% | 0.26% | 2.17% | 3.73% |
| Return on assets (ROA) | 4.70% | 4.70% | 4.92% | 4.83% | 4.53% | 3.61% | 2.67% | 2.66% | 2.02% | 1.87% | 2.58% | 2.33% | 3.06% | 3.31% | 1.59% | 0.57% | -0.45% | 12.01% | 12.93% | 14.24% |
| Return on total capital | 11.92% | 12.07% | 11.91% | 12.16% | 11.67% | 11.35% | 9.76% | 9.46% | 9.28% | 7.80% | 9.48% | 8.75% | 8.59% | 9.86% | 5.75% | 3.79% | 1.94% | 0.43% | 2.50% | 5.13% |
| Return on equity (ROE) | 8.50% | 8.64% | 8.96% | 8.89% | 8.26% | 6.50% | 4.93% | 4.90% | 3.73% | 3.39% | 4.81% | 4.51% | 5.93% | 6.42% | 3.11% | 1.13% | -0.91% | 23.80% | 25.53% | 31.06% |
Boston Scientific Corp's profitability ratios have shown a positive trend over the past few years.
- Operating return on assets (Operating ROA) has been increasing steadily from 3.73% as of March 31, 2020, to 7.23% by December 31, 2024. This indicates the company's ability to generate profit from its operating activities in relation to its total assets.
- Return on assets (ROA) has also shown improvement, with an increase from 14.24% in March 31, 2020, to 4.70% by December 31, 2024. This ratio indicates the company's efficiency in generating profit from its assets, including both operating and non-operating activities.
- Return on total capital has shown a consistent increase from 5.13% as of March 31, 2020, to 11.92% by December 31, 2024. This ratio reflects Boston Scientific Corp's ability to generate profit in relation to its total invested capital, including debt and equity.
- Return on equity (ROE) has also exhibited a positive trend, increasing from 31.06% in March 31, 2020, to 8.50% by December 31, 2024. ROE highlights the company's profitability in relation to shareholder equity, indicating how well it is utilizing equity investments to generate profit.
Overall, the increasing trend in these profitability ratios suggests that Boston Scientific Corp has been effectively managing its assets, capital, and equity to generate higher returns for its investors over the analyzed period.
See also:
Boston Scientific Corp Profitability Ratios (Quarterly Data)